|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5739018A
(en)
|
1996-08-07 |
1998-04-14 |
The Regents Of The University Of California |
Packaging cell lines for pseudotyped retroviral vectors
|
|
US6207455B1
(en)
|
1997-05-01 |
2001-03-27 |
Lung-Ji Chang |
Lentiviral vectors
|
|
JP4390860B2
(ja)
|
1997-05-13 |
2009-12-24 |
ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
レンチウイルスをベースにした遺伝子転移ベクター
|
|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
JP2002538842A
(ja)
|
1999-03-16 |
2002-11-19 |
デイナ−ファーバー キャンサー インスティチュート，インコーポレイテッド |
大量のスクリーニングのためのレンチウイルスベクター系
|
|
ATE351916T1
(de)
|
1999-10-12 |
2007-02-15 |
Pasteur Institut |
Lentivirale triplex-dns, und vektoren und rekombinante zellen, die lentivirale triplex-dns enthalten
|
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
|
US7135339B2
(en)
|
2003-11-20 |
2006-11-14 |
University Of Iowa Research Foundation |
Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
|
|
EP1769078A1
(en)
|
2004-07-01 |
2007-04-04 |
VIRxSYS Corporation |
Vector packaging cell line
|
|
JP2006085744A
(ja)
|
2004-09-14 |
2006-03-30 |
Matsushita Electric Ind Co Ltd |
磁気記録再生装置及びそのテープスレッディング方法
|
|
WO2007095201A2
(en)
|
2006-02-15 |
2007-08-23 |
The Regents Of The University Of California |
Pseudotyped retroviral vectors and methods of use thereof
|
|
CA2651174A1
(en)
|
2006-05-03 |
2007-11-15 |
Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services |
Chimeric t cell receptors and related materials and methods of use
|
|
US8293685B2
(en)
|
2007-07-26 |
2012-10-23 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
|
US9273283B2
(en)
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
|
GB0920775D0
(en)
|
2009-11-26 |
2010-01-13 |
King S College |
Cells
|
|
EP2895203A4
(en)
|
2012-06-15 |
2016-09-28 |
Imaginab Inc |
ANTIGENBINDING CONSTRUCTS FOR CD3
|
|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
WO2015017214A1
(en)
|
2013-07-29 |
2015-02-05 |
Bluebird Bio, Inc. |
Multipartite signaling proteins and uses thereof
|
|
US10287354B2
(en)
*
|
2013-12-20 |
2019-05-14 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
|
US20170081411A1
(en)
|
2014-03-15 |
2017-03-23 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
|
EP3593812A3
(en)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Treatment of cancer using chimeric antigen receptor
|
|
DK3166968T3
(da)
|
2014-05-02 |
2021-12-06 |
Univ Pennsylvania |
Sammensætninger og fremgangsmåder til kimæriske autoantistofreceptor-T-celler
|
|
GB201412494D0
(en)
|
2014-07-14 |
2014-08-27 |
Ospedale San Raffaele And Fond Telethon |
Vector production
|
|
CN107531800B
(zh)
|
2014-07-25 |
2021-08-10 |
赛拉福柯蒂斯公司 |
用于嵌合抗原受体分子的调控表达的慢病毒载体
|
|
TWI805109B
(zh)
|
2014-08-28 |
2023-06-11 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
|
WO2016118775A1
(en)
|
2015-01-21 |
2016-07-28 |
Fred Hutchinson Cancer Research Center |
Cocal envelope pseudotyped retroviral vector producer cells
|
|
JP7237449B2
(ja)
|
2015-02-27 |
2023-03-13 |
アイセル・ジーン・セラピューティクス・エルエルシー |
血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法
|
|
GB201503500D0
(en)
|
2015-03-02 |
2015-04-15 |
Ucl Business Plc |
Cell
|
|
EP3270943A4
(en)
|
2015-03-16 |
2018-10-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Isolated peptides derived from the b7 ligand dimer interface and uses thereof
|
|
AU2016297014B2
(en)
|
2015-07-21 |
2021-06-17 |
Novartis Ag |
Methods for improving the efficacy and expansion of immune cells
|
|
GB201514875D0
(en)
|
2015-08-20 |
2015-10-07 |
Autolus Ltd |
Receptor
|
|
IL261713B2
(en)
|
2016-03-19 |
2023-09-01 |
F1 Oncology Inc |
Methods and preparations for the transfer of lymphocytes and their regulated expansion
|
|
JP7282521B2
(ja)
|
2016-04-08 |
2023-05-29 |
パーデュー・リサーチ・ファウンデイション |
Ｃａｒ ｔ細胞療法のための方法および組成物
|
|
EP3458485B1
(en)
*
|
2016-05-19 |
2021-12-29 |
The General Hospital Corporation |
Tethered interleukin-2 to its receptor il-2rbeta, a platform to enhance natural killer and regulatory t cell activity
|
|
EP3512540A1
(en)
|
2016-09-14 |
2019-07-24 |
Université Catholique de Louvain |
Modified vsv-g and vaccines thereof
|
|
JP7206214B2
(ja)
|
2016-12-13 |
2023-01-17 |
シアトル チルドレンズ ホスピタル （ディービーエイ シアトル チルドレンズ リサーチ インスティテュート） |
インビトロ及びインビボで操作された細胞において発現された化学誘導シグナル伝達複合体の外因性薬物活性化の方法
|
|
US11613574B2
(en)
|
2017-01-10 |
2023-03-28 |
The General Hospital Corporation |
Methods and compositions relating to ex vivo culture and modulation of T cells
|
|
CN110612119B
(zh)
|
2017-02-07 |
2024-10-29 |
西雅图儿童医院（Dba西雅图儿童研究所） |
磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂
|
|
CN110662839A
(zh)
|
2017-02-17 |
2020-01-07 |
珀杜研究基金会 |
用于细胞疗法的基于靶向性配体-有效负载的药物递送
|
|
JP7178355B2
(ja)
|
2017-02-28 |
2022-11-25 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための組成物および方法
|
|
CN111479921B
(zh)
|
2017-09-18 |
2024-08-02 |
埃克苏马生物技术公司 |
用于以基因方式修饰且扩增淋巴细胞以及调节其活性的方法及组合物
|
|
CA3083786A1
(en)
|
2017-12-07 |
2019-06-13 |
Dermavant Sciences GmbH |
Topical ointment formulations of pde-4 inhibitor and their use in treating skin conditions
|
|
JP7549303B2
(ja)
|
2018-01-22 |
2024-09-11 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞の使用方法
|
|
SG11202007426XA
(en)
|
2018-02-06 |
2020-09-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
|
|
US20210038646A1
(en)
|
2018-02-12 |
2021-02-11 |
The General Hospital Corporation |
Chimeric antigen receptors targeting the tumor microenvironment
|
|
CN112262214A
(zh)
|
2018-04-12 |
2021-01-22 |
优莫佳生物制药股份有限公司 |
病毒载体及包装细胞系
|
|
KR20210074274A
(ko)
|
2018-08-06 |
2021-06-21 |
시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 |
합텐 표지된 세포로의 키메라 항원 수용체 t 세포의 자극을 위한 방법 및 조성물
|
|
KR20210042125A
(ko)
|
2018-08-07 |
2021-04-16 |
퍼듀 리서치 파운데이션 |
Car t 세포의 회생
|
|
WO2020106992A1
(en)
|
2018-11-21 |
2020-05-28 |
Umoja Biopharma, Inc. |
Multicistronic vector for surface engineering lentiviral particles
|
|
PL3886894T3
(pl)
|
2018-11-30 |
2024-07-01 |
Juno Therapeutics, Inc. |
Metody dawkowania i leczenia nowotworów b-komórkowych w adoptywnej terapii komórkowej
|
|
US20240122978A1
(en)
|
2019-10-16 |
2024-04-18 |
Umoja Biopharma, Inc. |
Retroviral vector for univeral receptor therapy
|
|
WO2021242719A1
(en)
|
2020-05-27 |
2021-12-02 |
The Medical College Of Wisconsin, Inc. |
Improved lentiviral vector transfer plasmid and methods of use
|
|
US11517814B2
(en)
|
2020-09-03 |
2022-12-06 |
Alan Chalmers |
Flavour system
|
|
CA3199588A1
(en)
|
2020-11-20 |
2022-05-27 |
Andrew Scharenberg |
Vector system for delivery of multiple polynucleotides and uses thereof
|
|
MX2023008831A
(es)
|
2021-01-27 |
2023-10-19 |
Umoja Biopharma Inc |
Lentivirus para generar células que expresan receptores de antígeno quimérico anti-cd19.
|
|
JP2025517138A
(ja)
|
2022-05-06 |
2025-06-03 |
ウモジャ バイオファーマ インコーポレイテッド |
表面刺激分子を有するウイルス粒子
|